Literature DB >> 28124611

ImmunemiR - A Database of Prioritized Immune miRNA Disease Associations and its Interactome.

Archana Prabahar1, Jeyakumar Natarajan2.   

Abstract

BACKGROUND: MicroRNAs are the key regulators of gene expression and their abnormal expression in the immune system may be associated with several human diseases such as inflammation, cancer and autoimmune diseases. Elucidation of miRNA disease association through the interactome will deepen the understanding of its disease mechanisms. A specialized database for immune miRNAs is highly desirable to demonstrate the immune miRNA disease associations in the interactome.
METHODS: miRNAs specific to immune related diseases were retrieved from curated databases such as HMDD, miR2disease and PubMed literature based on MeSH classification of immune system diseases. The additional data such as miRNA target genes, genes coding protein-protein interaction information were compiled from related resources. Further, miRNAs were prioritized to specific immune diseases using random walk ranking algorithm.
RESULTS: In total 245 immune miRNAs associated with 92 OMIM disease categories were identified from external databases. The resultant data were compiled as ImmunemiR, a database of prioritized immune miRNA disease associations. This database provides both text based annotation information and network visualization of its interactome.
CONCLUSION: To our knowledge, ImmunemiR is the first available database to provide a comprehensive repository of human immune disease associated miRNAs with network visualization options of its target genes, protein-protein interactions (PPI) and its disease associations. It is freely available at http://www.biominingbu.org/immunemir/. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Autoimmune disease; PPI interactome; immune; miRNA; miRNA-disease association

Mesh:

Substances:

Year:  2017        PMID: 28124611     DOI: 10.2174/2211536606666170117112322

Source DB:  PubMed          Journal:  Microrna


  7 in total

1.  Motif scraper: a cross-platform, open-source tool for identifying degenerate nucleotide motif matches in FASTA files.

Authors:  Elisha D O Roberson
Journal:  Bioinformatics       Date:  2018-11-15       Impact factor: 6.937

2.  Immune promotive effect of bioactive peptides may be mediated by regulating the expression of SOCS1/miR-155.

Authors:  Caixia Chen; Xiulan Su; Zhiwei Hu
Journal:  Exp Ther Med       Date:  2019-07-05       Impact factor: 2.447

3.  Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis.

Authors:  Lifang Ye; Yu Zuo; Hanbo Yang; Wenli Li; Qinglin Peng; Xin Lu; Guochun Wang; Xiaoming Shu
Journal:  J Immunol Res       Date:  2019-02-19       Impact factor: 4.818

4.  Identification of a novel immune-related microRNA prognostic model in clear cell renal cell carcinoma.

Authors:  Yuhe Guo; Xianbin Li; Junbin Zheng; Jiali Fang; Guanghui Pan; Zheng Chen
Journal:  Transl Androl Urol       Date:  2021-02

5.  Target-Dependent Coordinated Biogenesis of Secondary MicroRNAs by miR-146a Balances Macrophage Activation Processes.

Authors:  Susanta Chatterjee; Ishita Mukherjee; Shreya Bhattacharjee; Mainak Bose; Saikat Chakrabarti; Suvendra N Bhattacharyya
Journal:  Mol Cell Biol       Date:  2022-03-21       Impact factor: 5.069

6.  ncRI: a manually curated database for experimentally validated non-coding RNAs in inflammation.

Authors:  Shuyuan Wang; Shunheng Zhou; Haizhou Liu; Qianqian Meng; Xueyan Ma; Hui Liu; Lihong Wang; Wei Jiang
Journal:  BMC Genomics       Date:  2020-06-01       Impact factor: 3.969

Review 7.  miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.

Authors:  Maria Teresa Di Martino; Caterina Riillo; Francesca Scionti; Katia Grillone; Nicoletta Polerà; Daniele Caracciolo; Mariamena Arbitrio; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.